These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1760835)

  • 1. Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
    Jansen W; Prenzel R; Rappert B; Kümper H; Laufen H; Tauchert M
    Cardiology; 1991; 79 Suppl 2():78-85. PubMed ID: 1760835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
    Jansen W; Prenze R; Kümper H; Tauchert M
    Am J Cardiol; 1990 Jun; 65(21):16J-22J. PubMed ID: 2349913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
    Jansen W; Prenzel R; Kümper H; Weidmann B; Tauchert M
    Z Kardiol; 1989; 78 Suppl 2():72-8; discussion 115-7. PubMed ID: 2511697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
    Krepp HP
    Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
    J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
    Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
    An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
    Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
    Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.
    Stauch M; Grossmann G; Wanjura D; Adam WE
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S31-4. PubMed ID: 2354712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
    Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina].
    Lagioia R; Scrutinio D; Mangini SG; Mastropasqua F; Caporale R; Mancini G; Loliva F; Rizzon P
    Cardiologia; 1989 Feb; 34(2):155-60. PubMed ID: 2660992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.